Amir A. Al-Khami

3.1k citations

29 papers · 2.4k indexed · 1 hit paper · h-index 21

Co-authors: Paulo C. Rodrı́guez Augusto C. Ochoa Dorota Wyczechowska Luis Del Valle Fokhrul Hossain Liqin Zheng Claudia Hernandez Jimena Trillo-Tinoco
Topics: Immune Cell Function and Interaction (13 papers)Immune cells in cancer (11 papers)Cancer, Hypoxia, and Metabolism (6 papers)
Cited by: Immunology Cancer Research Oncology
Journals: Immunity The Journal of Immunology Cancer Research
Partner nations: United States Egypt India

In The Last Decade

Amir A. Al-Khami

29 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

2015 450 citations Fokhrul Hossain, Amir A. Al-Khami et al. Cancer Immunology Research profile →

Peers

Countries citing papers authored by Amir A. Al-Khami

Since Specialization

Citations

This map shows the geographic impact of Amir A. Al-Khami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir A. Al-Khami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir A. Al-Khami more than expected).

Fields of papers citing papers by Amir A. Al-Khami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir A. Al-Khami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir A. Al-Khami. The network helps show where Amir A. Al-Khami may publish in the future.

Co-authorship network of co-authors of Amir A. Al-Khami

This figure shows the co-authorship network connecting the top 25 collaborators of Amir A. Al-Khami. A scholar is included among the top collaborators of Amir A. Al-Khami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir A. Al-Khami. Amir A. Al-Khami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Mohamed A. Ghonim,Salomè V. Ibba,(unknown),Youssef Errami,(unknown),Matthew J. Dean,Ali H. El‐Bahrawy,Dorota Wyczechowska,(unknown),Luis Del Valle,Amir A. Al-Khami,Augusto C. Ochoa,A. Hamid Boulares	69
2	Combinatorial immunotherapy induces tumor-infiltrating CD8⁺ T cells with distinct functional, migratory, and stem-like properties 2021 ·Journal for ImmunoTherapy of Cancer ·Natalija Budimir,Joseph S. Dolina,Jie Wei,Xiao Wang,(unknown),Pamela Santiago,(unknown),Luca Micci,Amir A. Al-Khami,Sophia X. Pfister,Sripad Ram,Purnima Sundar,Graham D. Thomas,Hua Long,Wenjing Yang,Shobha Potluri,Shahram Salek‐Ardakani	16
3	Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody 2020 ·Molecular Cancer Therapeutics ·Amir A. Al-Khami,Sawsan Youssef,Yasmina Abdiche,HoangKim Nguyen,Joyce Chou,Christopher R. Kimberlin,Sherman M. Chin,Cris Kamperschroer,Bart Jessen,Brent Kern,Natalija Budimir,Christopher P. Dillon,Allison Xu,Jerry D. Clark,Jeffrey Chou,Eugenia Kraynov,Arvind Rajpal,John Lin,Shahram Salek‐Ardakani	11
4	Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells 2017 ·OncoImmunology ·Amir A. Al-Khami,Liqin Zheng,Luis Del Valle,Fokhrul Hossain,Dorota Wyczechowska,Jovanny Zabaleta,María de la Paz Sánchez,Matthew J. Dean,Paulo C. Rodrı́guez,Augusto C. Ochoa	260
5	Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity 2017 ·Frontiers in Immunology ·Paulo C. Rodrı́guez,Augusto C. Ochoa,Amir A. Al-Khami	212
6	Energy metabolic pathways control the fate and function of myeloid immune cells 2017 ·Journal of Leukocyte Biology ·Amir A. Al-Khami,Paulo C. Rodrı́guez,Augusto C. Ochoa	49
7	THE DUAL ACTIONS OF DNA REPAIR ENZYME, PARP‐1, IN COLON INFLAMMATION AND CARCINOGENESIS 2016 ·The FASEB Journal ·(unknown),Youssef Errami,Ali H. El‐Bahrawy,Amir A. Al-Khami,(unknown),Amarjit S. Naura,Matthew J. Dean,(unknown),Jeffrey Wang,Hassan Brim,Hassan Ashktorab,Paulo C. Rodrı́guez,Augusto C. Ochoa,Hamid Boulares	1
8	Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer 2016 ·OncoImmunology ·Amir A. Al-Khami,Paulo C. Rodrı́guez,Augusto C. Ochoa	51
9	PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function 2015 ·Journal of Translational Medicine ·Mohamed A. Ghonim,(unknown),Salomè V. Ibba,Amir A. Al-Khami,Jeffrey Wang,Paulo C. Rodrı́guez,(unknown),Ali H. El‐Bahrawy,Matthew R. Lammi,Moselhy S. Mansy,(unknown),Alistair J. Ramsay,Augusto C. Ochoa,Amarjit S. Naura,A. Hamid Boulares	43
10	Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapiesbreakdown → 2015 ·Cancer Immunology Research ·Fokhrul Hossain,Amir A. Al-Khami,Dorota Wyczechowska,Claudia Hernandez,Liqin Zheng,Krzystoff Reiss,Luis Del Valle,Jimena Trillo-Tinoco,Tomasz Maj,Weiping Zou,Paulo C. Rodrı́guez,Augusto C. Ochoa	450
11	l -Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells 2014 ·Cancer Research ·Matthew Fletcher,María E. Ramírez,Rosa A. Sierra,Patrick Raber,Paul Thevenot,Amir A. Al-Khami,(unknown),Claudia Hernandez,Dorota Wyczechowska,Augusto C. Ochoa,Paulo C. Rodrı́guez	219
12	Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions 2014 ·Cancer Research ·Pravin Kesarwani,Amir A. Al-Khami,Gina Scurti,(unknown),(unknown),Shahid Husain,Quan Fang,Osama Naga,Patricia Simms,Gyda Beeson,Christina Voelkel‐Johnson,Elizabeth Garrett‐Mayer,Craig C. Beeson,Michael I. Nishimura,Shikhar Mehrotra	39
13	The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors 2014 ·Immunity ·Paul Thevenot,Rosa A. Sierra,Patrick Raber,Amir A. Al-Khami,Jimena Trillo-Tinoco,(unknown),Augusto C. Ochoa,Yan Cui,Luis Del Valle,Paulo C. Rodrı́guez	198
14	A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo 2013 ·Journal of Investigative Dermatology ·Shilpak Chatterjee,Jonathan M. Eby,Amir A. Al-Khami,(unknown),Hee-Kap Kang,(unknown),Osama Naga,Anuradha K. Murali,Michael I. Nishimura,I. Caroline Le Poole,Shikhar Mehrotra	83
15	Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide 2012 ·Cellular Immunology ·Mohamed L. Salem,Amir A. Al-Khami,(unknown),Abdel‐Aziz A. Zidan,(unknown),C. Marcela Díaz‐Montero,David J. Cole	33
16	T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules 2011 ·Cytokine ·(unknown),Osama Naga,Håkan Norell,Amir A. Al-Khami,(unknown),Nitya G. Chakraborty,Christina Voelkel‐Johnson,Bijay Mukherji,Shikhar Mehrotra	32
17	Adoptive immunotherapy of cancer: Gene transfer of T cell specificity 2011 ·PubMed ·Amir A. Al-Khami,Shikhar Mehrotra,Michael I. Nishimura	9
18	Cyclophosphamide Induces Dynamic Alterations in the Host Microenvironments Resulting in a Flt3 Ligand-Dependent Expansion of Dendritic Cells 2010 ·The Journal of Immunology ·Mohamed L. Salem,Amir A. Al-Khami,Sabry El-Naggar,C. Marcela Díaz‐Montero,Yi‐An Chen,David J. Cole	47
19	Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C) 2009 ·The Journal of Immunology ·Mohamed L. Salem,C. Marcela Díaz‐Montero,Amir A. Al-Khami,Sabry El-Naggar,Osama Naga,Alberto J. Montero,(unknown),David J. Cole	90
20	Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses 2009 ·Immunology Endocrine & Metabolic Agents - Medicinal Chemistry ·Mohamed L. Salem,Faris Q Alenzi,Narender Nath,Sabry El-Naggar,Amir A. Al-Khami,Ali A. Al‐Jabri,Jamal M. Arif,Eman Mohamad El Nashar,(unknown),Richard Wyse	4

About Amir A. Al-Khami

Amir A. Al-Khami is a scholar working on Immunology, Oncology and Biological Psychiatry, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Immune cells in cancer (11 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Immunology (1.5k citations), Cancer Research (572 citations) and Oncology (652 citations). Amir A. Al-Khami has collaborated with scholars based in United States, Egypt and India. Frequent co-authors include Paulo C. Rodrı́guez, Augusto C. Ochoa, Dorota Wyczechowska, Luis Del Valle, Fokhrul Hossain, Liqin Zheng, Claudia Hernandez, Jimena Trillo-Tinoco, Shikhar Mehrotra and Anuradha K. Murali. Their work appears in journals such as Immunity, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact